Form 4 holding
Reporting Person's title: President and Chief Executive Officer, Director
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 712,826
- Estimated value
- $22,713,059
- Report date
- 02 Nov 2026
- Price
- $31.86
- Ownership
- Direct